,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #cdjh  ,,in ,,the ,,house ,,of  
,,representatives  ,june #ba1 #bjai,mr4 
,arrington 7for himself and ,mr4 ,olson7
 introduced the following bill2 which   
was referred to the ,committee on       
,energy and ,commerce1 and in addition  
to the ,committee on ,ways and ,means1  
for a period to be subsequently         
determined by the ,speaker1 in each case
 for consideration of such provisions as
 fall within the jurisdiction of the    
committee concerned  ,a ,,bill  ,to     
amend title ,,xviii of the ,social      
,security ,act to require prescription  
drug plan sponsors to include real-time 
benefit information as part of such     
sponsor's electronic prescription       
program under the ,medicare program4    
#a4 ,short title ,this ,act may be cited
 as the ,shop ,rx ,act of #bjai4  #b4   
,requiring prescription drug plan       
sponsors to include real-time benefit   
information as part of such sponsor's   
electronic prescription program under   

the ,medicare program ,section          
#ahfj;,d-#d7;e77#b7 of the ,social      
,security ,act 7#db ,u4,s4,c4           
#aciew-#ajd7;e77#b77 is amended--  7#a7 
in subparagraph 7,d71 by striking ,to   
the extent and inserting ,except as     
provided in subparagraph 7,f71 to the   
extent2 and  7#b7 by adding at the end  
the following new subparagraph3  7,f7   
,real-time benefit information  7i7 ,in 
general ,not later than ,january #a1    
#bjba1 the program shall provide for the
 real-time electronic transmission to   
prescribing health care professionals1  
using technology capable of integrating 
with such professionals' electronic     
prescribing and electronic health record
 systems1 of individual-specific        
formulary and benefit information under 
a prescription drug plan with respect to
 an individual enrolled in such plan4   
,such information shall include1 with   
respect to the prescribing of a covered 
part ,d drug to such individual1 the    
following3  7,i7 ,a description of any  

clinically appropriate alternatives to  
such drug included in the formulary of  
such plan4  7,,ii7 ,information relating
 to applicable cost-sharing requirements
 for such drug and such alternatives1   
including a description of any variance 
in such requirements based on the       
pharmacy dispensing such drug or such   
alternatives4  7,,iii7 ,information     
relating to any prior authorization or  
other utilization management            
requirements applicable to such drug and
 such alternatives within the formulary 
of such plan4  7ii7 ,special rule for   
#bjba ,the program shall be deemed to be
 in compliance with clause 7i7 for #bjba
 if the program complies with the       
provisions of section #dbc4afj7;b77#g7  
of title #db1 ,code of ,federal         
,regulations 7or a successor            
regulation71 for such year4  4